Adenovirus-associated viral vector-based gene-replacement therapy for the treatment of arrhythmogenic cardiomyopathy: A risk–benefit perspective in an evolving field
Year: 2026
Type: review
Source: Heart Rhythm
Institutions: Johns Hopkins University, Johns Hopkins Medicine
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7147616594
